Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Manchester United PLC — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Manchester United PLC trades at $20.68 (market cap $3.64B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 2.3× Manchester United PLC's market cap, and Manchester United PLC pays a 1.26% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Manchester United PLC for 109 Days on average.
| HNGE | MANU | |
|---|---|---|
Market Cap | $8.48B | $3.64B |
Volume | 879,799 | 324,608 |
Sector | Health | Media |
52-Week High | $105.14 | $24.19 |
52-Week Low | $31.17 | $15.20 |
Typical Hold Time | 0 Days | 109 Days |
Enterprise Value | $8.10B | $4.46B |
Dividend Yield | — | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Manchester United (MANU) trades at $20.59, down 1.15% today, with mixed technical signals showing bullish moving averages but neutral oscillators. The company reported fiscal 2026 revenue of $678 million with improved EBITDA of $216.4 million despite net losses, while analyst sentiment remains divided with 40% buy ratings. Recent news highlights the stock trading at a significant discount to Forbes' $7.2 billion franchise valuation estimate.
Investment outlook balances franchise value upside against persistent profitability challenges. Key opportunities include Champions League return and cost controls, while risks center on sustained losses, high debt, and competitive Premier League dynamics. The stock offers speculative appeal for franchise value believers but requires profitability improvement for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
